Turtle Creek Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Turtle Creek Wealth Advisors's REGN Position: Q2 2026 in Review
Turtle Creek Wealth Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 25% in Q2 2026, selling an estimated $78.3K and leaving 339 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #441.
Turtle Creek Wealth Advisors first reported a position in REGN in Q4 2023 and has held it in 4 quarters since. The position peaked at $351K in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Turtle Creek Wealth Advisors held 339 shares of Regeneron Pharmaceuticals worth $211K as of Q2 2026.
- Turtle Creek Wealth Advisors sold 115 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $78.3K.
- Regeneron Pharmaceuticals made up 0.01% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #441 holding.
- Turtle Creek Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
- Turtle Creek Wealth Advisors's Regeneron Pharmaceuticals position peaked at $351K in Q1 2026.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.